Patents by Inventor Kouji Imamura

Kouji Imamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of constructing recombinant proteoliposome for diagnostic use
    Patent number: 8563291
    Abstract: [PROBLEMS] To provide a method for preparation of recombinant proteoliposomes suitable for diagnostic applications, a detection plate coated with the recombinant proteoliposomes, a detection kit and so on. [PROBLEM-SOLVING MEANS] Recombinant proteoliposomes are prepared by fusion of budded virus particles of a recombinant baculovirus, expressing a target membrane receptor (such as human thyroid-stimulating hormone receptor, acetylcholine receptor, insulin receptor, ?1 adrenergic receptor, asialoglycoprotein receptor, etc., each participating in an autoantibody-related disease), with liposomes. Compared with the recombinant baculoviruses, these proteoliposomes have an improved ability to bind to an autoantibody and makes it possible to produce easily a kit for its detection.
    Type: Grant
    Filed: February 15, 2007
    Date of Patent: October 22, 2013
    Assignee: Mie University
    Inventors: Tetsuro Yoshimura, Kanta Tsumoto, Kouji Imamura, Kazuhiko Morino, Jun Kobayashi
  • Method of Constructing Recombinant Proteoliposome for Diagnostic Use
    Publication number: 20090186364
    Abstract: [PROBLEMS] To provide a method for preparation of recombinant proteoliposomes suitable for diagnostic applications, a detection plate coated with the recombinant proteoliposomes, a detection kit and so on. [PROBLEM-SOLVING MEANS] Recombinant proteoliposomes are prepared by fusion of budded virus particles of a recombinant baculovirus, expressing a target membrane receptor (such as human thyroid-stimulating hormone receptor, acetylcholine receptor, insulin receptor, ?1 adrenergic receptor, asialoglycoprotein receptor, etc., each participating in an autoantibody-related disease), with liposomes. Compared with the recombinant baculoviruses, these proteoliposomes have an improved ability to bind to an autoantibody and makes it possible to produce easily a kit for its detection.
    Type: Application
    Filed: February 15, 2007
    Publication date: July 23, 2009
    Applicant: MIE UNIVERSITY
    Inventors: Tetsuro Yoshimura, Kanta Tsumoto, Kouji Imamura, Kazuhiko Morino, Jun Kobayashi
  • Sustained release hair growth composition
    Patent number: 6255313
    Abstract: A sustained hair growth preparation comprising minoxidil and dipropylene glycol makes it possible to retain the absorbed minoxidil in the dermis and to increase the concentration of the minoxidil around the hair bulbs which are the hair growing sites, thereby making it possible to give a sufficient hair growth effect.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: July 3, 2001
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Kenichi Suzuki, Kouji Imamura, Susumu Morioka, Shigeo Tanaka